Biological assessment of New Molecular Entities (NMEs) plays a crucial role in ascertaining structure activity relationships, potency, selectivity, drugability and in vivo efficacy evaluation.
The scope of Biology services at GVK BIO encompasses in vivo and in vitro profiling of molecules for their activity, potency, efficacy, ADME and toxicity. To gain from these services we offer, an increasing base of pharmaceutical companies worldwide is choosing GVK BIO for its outsourcing needs in Biology.
In addition to Biology standalone services, one of the principal benefits to our clients is our Integrated Services Platform. This allows access to multiple and seamless outsourcing choices across the drug discovery chain, ensuring speedy implementation of their research projects. They also stand to benefit from the fact that the Biology services at GVK BIO complement our strengths and capabilities in other departments, like Medicinal Chemistry, Informatics and Clinical Research. Capitalizing on our Biology strengths, our clients have advanced their early discovery programs. They have accelerated their research, and built and developed a strong pipeline, in a short span of time.